Related Experiment Video
Updated: Apr 12, 2026

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
Pulmonary multifunctional nano-oncological modules for lung cancer treatment and prevention
Abstract:
Mortality associated with lung cancer and its metastasis has outnumbered those related to other forms of cancer. Despite being a directly accessible organ, conventional oncological strategies exhibiting prolific outcome in treatment and prevention of lung cancer is far from reality. This is attributed to numerous challenges posed by lung environment. The extracellular aura of lung comprises immensely complicated structures, ciliary escalators, omnipresence of mucus and alveolar fluid, and macrophagial uptake which presents an array of impediments to the arrival of therapeutic moiety at the tumor site. Besides these, intracellular obstacles viz enzymatic degradation, cell membrane translocation, endosomal escape and/or nuclear entry also limit superior therapeutic efficacy. The current review elaborates wide-ranging challenges to lung cancer treatment and its circumvention by latest developments in multifunctional nano-oncological modules delivered via the pulmonary route-which smartly deal with the abovementioned issues and bestow positivity to this complication.
Insights
Lung cancer treatment faces significant hurdles due to the lung
Area of Science:
- Oncology and Nanotechnology
- Pulmonary Drug Delivery
Background:
- Lung cancer mortality remains high, despite the lung being an accessible organ.
- Conventional lung cancer treatments face challenges from the complex lung environment.
- Extracellular and intracellular barriers impede therapeutic efficacy in lung cancer.
Purpose of the Study:
- To review the challenges in lung cancer treatment.
- To explore advanced nano-oncological modules for pulmonary drug delivery.
- To highlight strategies overcoming lung-specific therapeutic impediments.
Main Methods:
- Review of current literature on lung cancer treatment challenges.
- Analysis of multifunctional nano-oncological modules for pulmonary delivery.
- Examination of strategies to overcome extracellular and intracellular barriers.
Main Results:
- The lung's complex extracellular environment (mucus, fluid, cilia) hinders drug delivery.
- Intracellular barriers (enzymatic degradation, translocation, endosomal escape) limit treatment effectiveness.
- Multifunctional nano-oncological modules offer promising solutions for pulmonary drug delivery.
Conclusions:
- Overcoming lung-specific barriers is crucial for effective lung cancer therapy.
- Nanotechnology-based pulmonary delivery systems show potential to enhance treatment outcomes.
- Advanced nano-modules can address both extracellular and intracellular challenges in lung cancer.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...

